Related Experiment Video
Updated: May 27, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Should patients with erectile dysfunction be evaluated for cardiovascular disease?
Kenneth A Ewane1, Hao-Cheng Lin, Run Wang
1Division of Urology, University of Texas Medical School at Houston, 77030, USA.
Erectile dysfunction (ED) is linked to cardiovascular disease (CVD), but it is not a better predictor than existing risk factors. Screening for CVD may benefit younger men with severe ED and those with existing CVD risk factors.
Area of Science:
- Cardiology
- Urology
- Gerontology
Background:
- Erectile dysfunction (ED) is increasingly recognized as a condition associated with aging.
- A significant link exists between ED and the development of cardiovascular disease (CVD).
- Shared risk factors contribute to both ED and CVD, prompting research into ED as a potential CVD marker.
Purpose of the Study:
- To investigate the potential of using ED as a screening tool for future CVD.
- To determine if ED is an independent risk predictor for CVD compared to established factors.
Main Methods:
- A comprehensive literature search of PubMed and Cochrane Library databases was conducted.
- English-language articles published between January 2000 and June 2011 discussing ED and CVD were reviewed.
- Included study types: randomized controlled trials, cohort studies, retrospective studies, and review articles.
Main Results:
- A correlation was found between ED and the future development of CVD in some individuals.
- ED did not emerge as an independent risk predictor superior to traditional Framingham risk factors.
- Screening for CVD may be beneficial in younger patients with severe ED and those with concurrent CVD risk factors.
Conclusions:
- While ED is linked to CVD, it does not outperform established risk assessment tools.
- Consideration of ED as a CVD screening indicator is warranted for specific patient groups.
- Further research may refine the role of ED in cardiovascular risk stratification.
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Coronary Artery Disease I: Introduction